Claims against Dr Reddy’s over Revlimid in US dismissed

Dr Reddy’s Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.

In a regulatory filing, the company said on December 22, 2022 and December 27, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Ltd and Dr Reddy’s Laboratories, Inc. Respectively, from the case.

“All claims against the company in the litigation have now been dismissed,” Dr Reddy’s said.

Last month the company had stated that it was among several generic pharmaceutical companies, including Celgene and Bristol Myers Squibb, against which an antitrust litigation has been filed in the District of New Jersey, USA.

The complaint had asserted “claims under federal and state antitrust law and other state laws alleging that defendants improperly restrained competition and maintained a shared monopoly in the sale of brand and generic Revlimid in the United States.”

Also read- Lumpsum Investment: What it is and how it works – Key things to know

The company had stated that the complaint “alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly limited generic competition through 2026.”

The complaint seeks damages for purported overpayments and equitable relief, it added.

Click Here For Latest Updates On Stock Market | Zee Business Live

"); if ((i + 1) % 3 == 0 && (i + 1) > 2 && $(this).html().length > 20 && ci < pl && adcount < 3) { if (adcount == 2) { $('

').insertAfter } adcount++; } else if (adcount >= 3) { return false; } }); } $(fb_script).appendTo(fmain); $(fdiv).appendTo(fmain); var rightside = $('div#main-rhs215071 > div.main-contents:first').clone(); var outpg = $('body').children('.outpage'); $(".sidebar215071").theiaStickySidebar(); if ($.autopager) { var use_ajax = true;

function loadshare(curl) { history.pushState('', '', curl); if (window.OBR) { window.OBR.extern.researchWidget(); } if (_up == false) { var cu_url = curl; ga('set', 'page', curl); ga('send', 'pageview'); } } if (use_ajax == false) { var view_selector="div#maincontent"; var content_selector = view_selector; var items_selector = content_selector + ' > div.repeat-block'; var pager_selector="div.view-zbiz-article-prev-next > div.view-content > div > div.next-article-blick-biz"; var next_selector="div.view-zbiz-article-prev-next > div.view-content > div > div.next-article-blick-biz > a:last"; var auto_selector="div.view-zbiz-article-prev-next"; var img_location = view_selector + ' > div.repeat-block:last'; var img_path=""; var img = '

'; var x = 0; var url=""; var prevLoc = window.location.pathname; var circle = ""; var myTimer = ""; var interval = 30; var angle = 0; var Inverval = ""; var angle_increment = 6; var handle = $.autopager({ appendTo: content_selector, content: items_selector, runscroll: maindiv, link: next_selector, autoLoad: false, page: 0, start: function () { $(img_location).after(img); }, load: function () { $('#views_infinite_scroll-ajax-loader').remove(); $('div#main-rhs' + x).empty(); //console.log($('div#main-rhs215071 > div.sidebar215071 > div:first').text()); $('#maincontent >.row:last').before('

'); $(rightside).clone().appendTo('div#main-rhs' + x); $(".sidebar" + x).theiaStickySidebar(); var fb_script = document.createElement('script'); fb_script.text = "(function(d, s, id) {var js, fjs = d.getElementsByTagName(s)[0];if (d.getElementById(id)) return;js = d.createElement(s); js.id = id;js.src="https://connect.facebook.net/en_GB/sdk.js#xfbml=1&version=v2.9";fjs.parentNode.insertBefore(js, fjs);}(document, 'script', 'facebook-jssdk'));"; var fmain = $(".sr" + x); var fdiv = '

'; $(fdiv).appendTo(fmain); FB.XFBML.parse(); var $dfpAd = $('#maincontent').children().find("#ad-" + x); var $dfpAdMob = $('#maincontent').children().find("#ad-mob-" + x); var $dfpAdrhs = $('#main-rhs' + x).children().find('.adATF').empty().attr("id", "ad-300-" + x); var $dfpAdrhs2 = $('#main-rhs' + x).children().find('.adBTF').empty().attr("id", "ad-300-2-" + x); $('body').children('.outpage').empty().append('

 

'); var $dfpAdOutofpage = $('body').children('div.opage'); var instagram_script = document.createElement('script'); instagram_script.defer="defer"; instagram_script.async="async"; instagram_script.src="https://platform.instagram.com/en_US/embeds.js"; setTimeout(function () { var twit = $("div.field-name-body").find('blockquote[class^="twitter"]').length; var insta = $("div.field-name-body").find('blockquote[class^="instagram"]').length; if (twit == 0) { twit = ($("div.field-name-body").find('twitterwidget[class^="twitter"]').length); } if (twit > 0) { if (typeof (twttr) != 'undefined') { twttr.widgets.load();

} else { $.getScript('//platform.twitter.com/widgets.js'); } } if (insta > 0) { $('#maincontent >.row:last').after(instagram_script); window.instgrm.Embeds.process(); } }, 1500); } });

$(document).delegate("button[id^='mf']", "click", function () { fbcontainer=""; fbid = '#' + $(this).attr('id'); var sr = fbid.replace("#mf", ".sr");

$(fbid).parent().children(sr).toggle(); fbcontainer = $(fbid).parent().children(sr).children(".fb-comments").attr("id"); });

var title, imageUrl, description, author, shortName, identifier, timestamp, summary, newsID, nextnews; var previousScroll = 0; $(window).scroll(function () { var last = $(auto_selector).filter(':last'); var lastHeight = last.offset().top; var currentScroll = $(this).scrollTop(); if (currentScroll > previousScroll) { _up = false; } else { _up = true; } previousScroll = currentScroll; var cutoff = $(window).scrollTop() + 64; $('div[id^="row"]').each(function () { if ($(this).offset().top + $(this).height() > cutoff) { if (prevLoc != $(this).children().find('.article-box').attr('data-url')) { prevLoc = $(this).children().find('.article-box').attr('data-url'); $('html head').find('title').text($(this).children().find('.article-box').attr('data-title')); loadshare(prevLoc); } return false; // stops the iteration after the first one on screen } }); if (lastHeight + last.height() < $(document).scrollTop() + $(window).height()) { url = $(next_selector).attr('href'); x = $(next_selector).attr('id'); } }); } } }); } }; })(jQuery); ,

Source link

Leave a Comment

%d bloggers like this: